跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Boricetam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Boricetam
Approved
STANDARD
Boricetam
Brawn Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fb136d320c5a4686
Company
Brawn Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
fb136d320c5a4686
Drug Approval Philippines Name
Boricetam
Product Name
Boricetam
Registration Number
DRP-8045
Brand Name
Boricetam
Generic Name
Piracetam
Dosage Form
Solution for Injection (I.M./I.V.)
Dosage Strength
200mg/Ml (1g/5mL)
Manufacturer
Brawn Laboratories Ltd.
Importer
Ambica International Corp.
Distributor
Ambica International Corp.
Issuance Date
30 January 2023
Expiry Date
05 December 2028
Pharmacologic Category
Psychostimulant/ Nootropic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fb136d320c5a4686
Type
Standard
Back to Philippines FDA Approvals